Blog
CDMO Leadership Shuffles: Impact on Biotech
📌 Explore the impact of leadership shuffles at CDMOs in the biotech industry 🌍🔬. Find out why stability matters!
Biogen’s CDMO Revenues Set to Plummet!
📢 Biogen, a global biotech company, anticipates a decline in CDMO revenues as its Denmark commitments conclude. 😔
Revolutionizing Biopharmaceutical Market: ICH Q5A R2’s Game-Changing Impact
📢 Discover the Impact of ICH Q5A R2 on the Biopharmaceutical Market! ⚙️ Explore development, processing, manufacturing, and more! 🌍
Revolutionary Partnership Expands Cell Therapy Development
📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭
AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible
📢 AstraZeneca teams up with FasTCAR to fast-track cell therapy production, revolutionizing accessibility and affordability for patients. 🚀
Bio-Techne’s CGT Boosts Growth: Q2 Success
📣 Bio-Techne Q2: CGT is a major growth driver! 🧪 Increasing demand, 💼 expanding capacity, and 💰 future growth expected.
Revolutionary Partnership Quantifies Host Cell Proteins
📢 Dyadic International and Cygnus Technologies have partnered to quantify host cell proteins (HCPs) for biopharmaceutical development. 🧫
Revolutionary Low-Cost Alternative to E coli in Synthetic Biology
💡 Cornell University creates low-cost and scalable platform for synthetic biology using engineered Vibrio natriegens, competing with E. coli. 🧬🔬
Revolutionary Gene Therapy for Heart Failure: Promising Results!
💉 Bayer's AskBio unit begins Phase II testing of gene therapy AB-1002 for heart failure patients. Promising results!
Revolutionary German Start-up Introduces Eco-Friendly Lab Plastics
📢 German start-up Green Elephant Biotech introduces a plant-based 96-well microtitre plate made from corn starch, reducing CO2 emissions and plastic waste. 🌱🔬
